IMS Health (NYSE: RX), the world’s leading provider of market
intelligence to the pharmaceutical and healthcare industries, today
announced that David R. Carlucci, chairman and chief executive officer,
will speak to investors and analysts attending the Raymond James 30th
Annual Institutional Investors Conference, to be held at the JW Marriott
Orlando in Grande Lakes, Florida on March 8-11, 2009.
To listen to a live audio Webcast of the IMS presentation on Wednesday,
March 11, 2009 at 9:15 a.m. ET, go to http://www.wsw.com/webcast/rj43/rx/.
A replay of the presentation will be available for seven days.
About IMS
Operating in more than 100 countries, IMS Health is the world’s leading
provider of market intelligence to the pharmaceutical and healthcare
industries. With $2.3 billion in 2008 revenue and more than 50 years of
industry experience, IMS offers leading-edge market intelligence
products and services that are integral to clients’ day-to-day
operations, including product and portfolio management
capabilities; commercial effectiveness innovations; managed care and
consumer health offerings; and consulting and services solutions that
improve productivity and the delivery of quality healthcare worldwide.
Additional information is available at http://www.imshealth.com.
IMS Health
Darcie Peck, 203-845-5237
Investor Relations
dpeck@imshealth.com
